Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Nevin, Remington L ^a   Pietrusiak, Paul P ^b   Caci, Jennifer B ^c  

^a Army Medical Surveillance Activity   (United States)

^b U S ARMY CENTER FOR HEALTH PROMOTION AND PREVENTIVE MEDICINE   (United States)

^c Headquarters   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATOMOXETINE; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; DULOXETINE; ESCITALOPRAM; ETIRACETAM; FLUOXETINE; FLURAZEPAM; GABAPENTIN; LAMOTRIGINE; MEFLOQUINE; METHYLPHENIDATE; MIRTAZAPINE; MODAFINIL; NEFAZODONE; NEUROLEPTIC AGENT; NORTRIPTYLINE; OXCARBAZEPINE; PAROXETINE; PHENYTOIN; PREGABALIN; SEDATIVE AGENT; TOPIRAMATE; UNINDEXED DRUG; VALPROATE SEMISODIUM; ANTIMALARIAL AGENT;

ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG CONTRAINDICATION; FEMALE; HUMAN; MALARIA; MALE; NEUROLOGIC DISEASE; PERIODIC MEDICAL EXAMINATION; PREVALENCE; SOLDIER; ADOLESCENT; AFGHANISTAN; MIDDLE AGED; UNITED STATES;

ADOLESCENT; ADULT; AFGHANISTAN; ANTIMALARIALS; FEMALE; HUMANS; MALARIA; MALE; MEFLOQUINE; MIDDLE AGED; MILITARY PERSONNEL; PREVALENCE; UNITED STATES;

EID: 40149106343     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-30     Document Type: Article

References (17)

1. Malaria in US military forces: a description of deployment exposures from 2003 through 2006. P Ciminera J Brundage, Am J Trop Med Hyg 2007 76 275 279 17297035
2. An outbreak of malaria in US Army Rangers returning from Afghanistan. RS Kotwal RB Wenzel RA Sterling WD Porter NN Jordan BP Petrucelli, JAMA 2007 293 2 212 216 10.1001/jama.293.2.212 15644548
3. Prevention of malaria in long-term travelers. LH Chen ME Wilson P Schlagenhauf, JAMA 2007 296 18 2234 2244 10.1001/jama.296.18.2234 17090770
4. Controversies and misconceptions in malaria chemoprophylaxis for travelers. LH Chen ME Wilson P Schlagenhauf, JAMA 2007 297 2251 2263 10.1001/jama.297.20.2251 17519415
5. Mefloquine use and hospitalizations among US service members, 2002-2004. TS Wells TC Smith B Smith LZ Wang CJ Hansen RJ Reed WE Goldfinger TE Corbeil CN Spooner MAK Ryan, Am J Trop Med Hyg 2006 74 744 749 16687673
6. Roche Laboratories Inc, Lariam® (mefloquine hydrochloride) Complete Product Information Nutley, NJ 2004
7. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. MV Rubertone JF Brundage, Am J Public Health 2002 92 1900 1904 12453804
8. Conducting population behavioral health surveillance by using automated diagnostic and pharmacy data systems. JA Pavlin P Murdock E Elbert C Milliken S Hakre J Mansfield C Hoge, MMWR 2004 Suppl 53 166 172 15714647
9. U.S. Department of Health and Human Services, International Classification of Diseases 9th Revision Clinical Modification US Government Printing Office 1980
10. SAS Institute, SAS/STAT® 9.1 Users Guide SAS Institute 2004
11. Point: bias from the "healthy-warrior effect" and unequal follow-up in three government studies of health effects of the Gulf War. RW Haley, Am J Epidemiol 1998 148 315 23 9717872
12. Bringing the war back home: mental health disorders among 103,788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs facilities. KH Seal D Bertenthal CR Miner S Sen C Marmar, Arch Intern Med 2007 167 476 82 10.1001/archinte.167.5.476 17353495
13. Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. CW Hoge JL Auchterlonie CS Milliken, JAMA 2006 295 1023 32 10.1001/jama.295.9.1023 16507803
14. Pre-travel health, immunization status, and demographics of travel to the developing world for individuals visiting a travel medicine service. DR Hill, Am J Trop Med Hyg 1991 45 263 270 1877722
15. Tafenoquine: a promising new antimalarial agent. M Crockett KC Kain, Expert Opin Investig Drugs 2007 16 705 15 10.1517/13543784.16.5.705 17461742
16. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria. S Kitchener P Nasveld MD Edstein, Am J Trop Med Hyg 2007 76 494 6 17360873
17. Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel. TD Chinevere CK Murray E Grant Jr GA Johnson F Duelm DR Hospenthal, Mil Med 2006 171 905 7 17036616